Rotavirus Efficacy and Safety Trial (REST)(V260-006)

NCT00090233 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

69274

Enrollment

INDUSTRY

Sponsor class

Conditions

Rotavirus Infections

Interventions

BIOLOGICAL: Rotateq™
BIOLOGICAL: Comparator: Placebo

Sponsor

Merck Sharp & Dohme LLC